Increased CSF levels of IL-8 have been previously reported in patients with MS compared to controls (Matejčíková et al., 2017) and have been associated with worse MS disease course (Stampanoni Bassi et al., 2018). This evidence concerns the gene CXCL8 and myeloid sarcoma.